NEW YORK, March 16 (GenomeWeb News) - Sequenom yesterday missed its Nasdaq-imposed minimum requirement for continued listing after failing to lift its shares above $1 for at least 10 consecutive trading days over the past six months.
As GenomeWeb News reported last September, the company had until March 15 to comply with the minimum bid requirement. The shares were trading at $.73 during the mid-afternoon.
Calls to Sequenom were not returned. Nasdaq officials deferred to the company.
In spite of the threat of imminent delisting, Sequenom shares rallied today on news of a new product launch.